Parellada E - Search Results

1

Effectiveness of long-acting injectable risperidone versus oral antipsychotics in the treatment of recent-onset schizophrenia: a case-control study.

Barrio P, Batalla A, Castellví P, Hidalgo D, García M, Ortiz A, Grande I, Pons A, Parellada E. Barrio P, et al. Among authors: parellada e. Int Clin Psychopharmacol. 2013 Jul;28(4):164-70. doi: 10.1097/YIC.0b013e3283611cc3. Int Clin Psychopharmacol. 2013. PMID: 23587986

2

Striatal dopamine D2 receptor density in neuroleptic-naive and in neuroleptic-free schizophrenic patients: an 123I-IBZM-SPECT study.

Lomeña F, Catafau AM, Parellada E, Bernardo M, Font M, Gutiérrez F, Pavía J. Lomeña F, et al. Among authors: parellada e. Psychopharmacology (Berl). 2004 Mar;172(2):165-9. doi: 10.1007/s00213-003-1644-2. Epub 2003 Nov 18. Psychopharmacology (Berl). 2004. PMID: 14624330

3

Risperidone in the treatment of patients with delirium.

Parellada E, Baeza I, de Pablo J, Martínez G. Parellada E, et al. J Clin Psychiatry. 2004 Mar;65(3):348-53. doi: 10.4088/jcp.v65n0310. J Clin Psychiatry. 2004. PMID: 15096074 Clinical Trial.

4

Efficacy and safety of direct transition to risperidone long-acting injectable in patients treated with various antipsychotic therapies.

Möller HJ, Llorca PM, Sacchetti E, Martin SD, Medori R, Parellada E; StoRMi Study Group. Möller HJ, et al. Among authors: parellada e. Int Clin Psychopharmacol. 2005 May;20(3):121-30. doi: 10.1097/00004850-200505000-00001. Int Clin Psychopharmacol. 2005. PMID: 15812261 Clinical Trial.

5

Patients in the early phases of schizophrenia and schizoaffective disorders effectively treated with risperidone long-acting injectable.

Parellada E, Andrezina R, Milanova V, Glue P, Masiak M, Turner MS, Medori R, Gaebel W. Parellada E, et al. J Psychopharmacol. 2005 Sep;19(5 Suppl):5-14. doi: 10.1177/0269881105056513. J Psychopharmacol. 2005. PMID: 16144781 Clinical Trial.

6

Clinical experience and management considerations with long-acting risperidone.

Parellada E. Parellada E. Curr Med Res Opin. 2006 Feb;22(2):241-55. doi: 10.1185/030079906X80396. Curr Med Res Opin. 2006. PMID: 16466596 Review.

7

Lower striatal dopamine transporter binding in neuroleptic-naive schizophrenic patients is not related to antipsychotic treatment but it suggests an illness trait.

Mateos JJ, Lomeña F, Parellada E, Mireia F, Fernandez-Egea E, Pavia J, Prats A, Pons F, Bernardo M. Mateos JJ, et al. Among authors: parellada e. Psychopharmacology (Berl). 2007 Apr;191(3):805-11. doi: 10.1007/s00213-006-0570-5. Epub 2006 Sep 22. Psychopharmacology (Berl). 2007. PMID: 17019564 Clinical Trial.

8

Long-acting injectable risperidone in the treatment of schizophrenia in special patient populations.

Parellada E. Parellada E. Psychopharmacol Bull. 2007;40(2):82-100. Psychopharmacol Bull. 2007. PMID: 17514188 Review.

9

Antipsychotic treatment in a patient with schizophrenia undergoing hemodialysis.

Batalla A, Vera M, Torra M, Parellada E. Batalla A, et al. Among authors: parellada e. J Clin Psychopharmacol. 2010 Feb;30(1):92-4. doi: 10.1097/JCP.0b013e3181c827c4. J Clin Psychopharmacol. 2010. PMID: 20075665 No abstract available.

10

Safety and efficacy of long-acting injectable risperidone in daily practice: an open-label, noninterventional, prospective study in schizophrenia and related disorders.

Parellada E, Kouniakis F, Siurkute A, Schreiner A, Don L. Parellada E, et al. Int Clin Psychopharmacol. 2010 May;25(3):149-54. doi: 10.1097/YIC.0b013e328336c93f. Int Clin Psychopharmacol. 2010. PMID: 20305567

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters